387 related articles for article (PubMed ID: 34447225)
1. Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis.
Johnson SD; Olwenyi OA; Bhyravbhatla N; Thurman M; Pandey K; Klug EA; Johnston M; Dyavar SR; Acharya A; Podany AT; Fletcher CV; Mohan M; Singh K; Byrareddy SN
World J Gastroenterol; 2021 Aug; 27(29):4763-4783. PubMed ID: 34447225
[TBL] [Abstract][Full Text] [Related]
2. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
3. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
4. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system.
Williams A; Branscome H; Khatkar P; Mensah GA; Al Sharif S; Pinto DO; DeMarino C; Kashanchi F
J Neurovirol; 2021 Oct; 27(5):667-690. PubMed ID: 34581996
[TBL] [Abstract][Full Text] [Related]
6. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.
Din AU; Mazhar M; Waseem M; Ahmad W; Bibi A; Hassan A; Ali N; Gang W; Qian G; Ullah R; Shah T; Ullah M; Khan I; Nisar MF; Wu J
Biomed Pharmacother; 2021 Jan; 133():110947. PubMed ID: 33197765
[TBL] [Abstract][Full Text] [Related]
9. Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19.
Chen J; Hall S; Vitetta L
Rev Med Virol; 2021 Sep; 31(5):1-13. PubMed ID: 34546607
[TBL] [Abstract][Full Text] [Related]
10. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
Xu Y; Baylink DJ; Chen CS; Reeves ME; Xiao J; Lacy C; Lau E; Cao H
J Transl Med; 2020 Aug; 18(1):322. PubMed ID: 32847594
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms.
Settanni CR; Ianiro G; Ponziani FR; Bibbò S; Segal JP; Cammarota G; Gasbarrini A
World J Gastroenterol; 2021 Nov; 27(43):7433-7445. PubMed ID: 34887641
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
13. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection.
Manosso LM; Arent CO; Borba LA; Ceretta LB; Quevedo J; Réus GZ
Cells; 2021 Aug; 10(8):. PubMed ID: 34440767
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity and COVID-19 - The microbiotal connection.
Katz-Agranov N; Zandman-Goddard G
Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
[TBL] [Abstract][Full Text] [Related]
15. Roles of the gut microbiota in severe SARS-CoV-2 infection.
Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
[TBL] [Abstract][Full Text] [Related]
16. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
18. Coronavirus disease 2019 and the gut-lung axis.
Zhou D; Wang Q; Liu H
Int J Infect Dis; 2021 Dec; 113():300-307. PubMed ID: 34517046
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 pathogenesis.
Lamers MM; Haagmans BL
Nat Rev Microbiol; 2022 May; 20(5):270-284. PubMed ID: 35354968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
